Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype

Kosiborod, MN; Abildstrom, SZ; Borlaug, BA; Butler, J; Christensen, L; Davies, M; Hovingh, KG; Kitzman, DW; Lindegaard, ML; Moller, DV; Shah, SJ; Treppendahl, MB; Verma, S; Petrie, MC

Kosiborod, MN (通讯作者),Univ Missouri Kansas City, Sch Med, St Lukes Mid Amer Heart Inst, Dept Cardiovasc Dis, 4401 Wornall Rd, Kansas City, MO 64111 USA.

JACC-HEART FAILURE, 2023; 11 (8): 1000

Abstract

BACKGROUND The majority of patients with heart failure with preserved ejection fraction (HFpEF) have the obesity phenotype, but no therapies specifica......

Full Text Link